Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMC 3094142)

Published in Am J Physiol Gastrointest Liver Physiol on March 03, 2011

Authors

Erik N Hansen1, Robyn A Tamboli, James M Isbell, Jabbar Saliba, Julia P Dunn, Pamela A Marks-Shulman, Naji N Abumrad

Author Affiliations

1: Departments of Surgery, Vanderbilt Univ. School of Medicine, Nashville, TN 37232-2730, USA.

Associated clinical trials:

Ghrelin Changes After Roux-en-Y Gastric Bypass | NCT00765596

Articles citing this

Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat Commun (2015) 1.57

Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus. Indian J Endocrinol Metab (2012) 1.12

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc (2012) 1.11

Non-systemic drugs: a critical review. Curr Pharm Des (2012) 1.02

Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J Diabetes (2012) 0.98

Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) (2013) 0.90

Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction. Ann Surg (2014) 0.86

Overnutrition stimulates intestinal epithelium proliferation through β-catenin signaling in obese mice. Diabetes (2013) 0.82

Duodenal luminal nutrient sensing. Curr Opin Pharmacol (2014) 0.80

Evidence from a single individual that increased plasma GLP-1 and GLP-1-stimulated insulin secretion after gastric bypass are independent of foregut exclusion. Diabetologia (2014) 0.80

Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1. Diabetes (2011) 0.80

Menin and GIP are inversely regulated by food intake and diet via PI3/AKT signaling in the proximal duodenum. Nutr Diabetes (2012) 0.78

Intestinal sweet-sensing pathways and metabolic changes after Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol (2014) 0.77

Bile acids and bariatric surgery. Mol Aspects Med (2017) 0.75

The role of hormonal factors in weight loss and recidivism after bariatric surgery. Gastroenterol Res Pract (2013) 0.75

Recent advances in metabolic and bariatric surgery. F1000Res (2016) 0.75

Changes in glycemia, insulin and gut hormone responses to a slowly ingested solid low-carbohydrate mixed meal after laparoscopic gastric bypass or band surgery. Int J Obes (Lond) (2017) 0.75

Gastric bypass and duodenal and gastric feeding: a comment to Hansen et al. Am J Physiol Gastrointest Liver Physiol (2011) 0.75

Effects of gastrogastric fistula repair on weight loss and gut hormone levels. Obes Surg (2013) 0.75

Surgical cure for type 2 diabetes by foregut or hindgut operations: a myth or reality? A systematic review. Surg Endosc (2016) 0.75

Articles cited by this

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care (1999) 26.39

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91

Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care (1998) 8.29

Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg (2003) 6.50

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 4.19

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care (2007) 3.97

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg (2006) 3.97

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg (2004) 3.23

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg (2007) 3.02

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis (2007) 3.01

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg (2004) 2.95

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab (2006) 2.78

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) (2009) 2.70

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care (2010) 2.64

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab (2005) 2.18

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) (2008) 2.15

Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest (2004) 2.11

Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab (2010) 1.66

Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology (2010) 1.62

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg (2006) 1.60

Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg (2005) 1.53

How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery (2007) 1.49

Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes (2010) 1.46

Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg (2008) 1.45

Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg (2009) 1.29

Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg (2008) 1.25

Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report. Diabetes Care (2009) 1.25

Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab (2008) 1.22

The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. J Pediatr Surg (2010) 1.15

Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents. Obesity (Silver Spring) (2010) 1.02

Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery. Obes Res (2003) 1.00

Colocalization of GLP-1 and GIP in human and porcine intestine. Ann N Y Acad Sci (2000) 0.86

Articles by these authors

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care (2010) 2.64

The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock (2006) 2.04

Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma (2008) 1.81

Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology (2010) 1.62

Resident work hour limits and patient safety. Ann Surg (2005) 1.58

Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res (2010) 1.41

Physician shortages and our increasing dependence on the international medical graduate: is there a mutually beneficial solution? J Surg Educ (2009) 1.40

Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc Natl Acad Sci U S A (2012) 1.35

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg (2002) 1.25

Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care (2011) 1.21

Leiomyoma presenting as a massive calcified circumferential esophageal mass. Ann Thorac Surg (2013) 1.19

Endocrine and metabolic response to gastric bypass. Curr Opin Clin Nutr Metab Care (2009) 1.17

Body composition and energy metabolism following Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) (2010) 1.16

Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care (2012) 1.14

Risk factors for pressure ulcers in acute care hospitals. Wound Repair Regen (2008) 1.02

Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice. Ann Surg (2011) 1.01

Effect of preinjury statin use on mortality and septic shock in elderly burn patients. J Trauma (2010) 0.95

Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6. Am J Physiol Endocrinol Metab (2010) 0.94

Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus. Surgery (2006) 0.90

Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery (2009) 0.89

Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor. Am J Physiol Endocrinol Metab (2009) 0.89

Early weight regain after gastric bypass does not affect insulin sensitivity but is associated with elevated ghrelin. Obesity (Silver Spring) (2014) 0.88

Adenosine-5'-triphosphate (ATP) supplementation improves low peak muscle torque and torque fatigue during repeated high intensity exercise sets. J Int Soc Sports Nutr (2012) 0.87

Striatal dopamine homeostasis is altered in mice following Roux-en-Y gastric bypass surgery. ACS Chem Neurosci (2014) 0.86

Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity (Silver Spring) (2014) 0.85

High-dose antioxidant administration is associated with a reduction in post-injury complications in critically ill trauma patients. Injury (2010) 0.83

Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity. Obesity (Silver Spring) (2014) 0.82

Reduction in inflammatory gene expression in skeletal muscle from Roux-en-Y gastric bypass patients randomized to omentectomy. PLoS One (2011) 0.82

African Americans show increased risk for pressure ulcers: a retrospective analysis of acute care hospitals in America. Wound Repair Regen (2009) 0.80

International medical graduates in general surgery: increasing needs, decreasing numbers. J Am Coll Surg (2010) 0.79

Reduction of 8-iso-prostaglandin F2α in the first week after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) (2011) 0.79

Induction chemoradiotherapy and surgery for esophageal cancer: survival benefit with downstaging. Ann Thorac Surg (2013) 0.78

Arginine therapy for acute myocardial infarction. JAMA (2006) 0.78

Effects of proximal gut bypass on glucose tolerance and insulin sensitivity in humans. Diabetes Care (2013) 0.78

Vitamin D status affects strength gains in older adults supplemented with a combination of β-hydroxy-β-methylbutyrate, arginine, and lysine: a cohort study. JPEN J Parenter Enteral Nutr (2011) 0.76

Blunt posterior tracheal laceration and esophageal injury in a child. J Pediatr Surg (2009) 0.76

Prevalence and predictors of atrial fibrillation among patients undergoing bariatric surgery. Obes Surg (2014) 0.75

Increased COMT expression in PCOS biology. Mol Cell Endocrinol (2012) 0.75

Results of bariatric surgery. Annu Rev Nutr (2006) 0.75

Think, diagnose, and rethink. Am J Med (2009) 0.75

Repair of metabolic processes. Crit Care Med (2003) 0.75

Erratum: Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity (Silver Spring) (2016) 0.75